CSIMarket



Amgen Inc   (AMGN)
Other Ticker:  
 
 

AMGN's Operating Income Growth by Quarter and Year

Amgen Inc 's Operating Income results by quarter and year




AMGN Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 7,639.00 9,139.00 9,674.00
III Quarter September - - - -
II Quarter June - - - -
I Quarter March 0.00 - - -
FY   - 7,639.00 9,139.00 9,674.00



AMGN Operating Income first quarter 2022 Y/Y Growth Comment
Amgen Inc in the first quarter 2022 recorded Operating Loss of $ 0.00 millions.

According to the results reported in the first quarter 2022, Amgen Inc achieved the best Operating Income growth in Biotechnology & Pharmaceuticals industry. While Amgen Inc ' s Operating Income no change of % ranks overall at the positon no. in the first quarter 2022.

Explain Operating Income growth


AMGN Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - -16.41 % -5.53 % 306.13 %
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - -16.41 % -5.53 % -5.74 %

Financial Statements
Amgen Inc 's first quarter 2022 Operating Income $ 0.00 millions AMGN's Income Statement
Amgen Inc 's first quarter 2021 Operating Income $ 0.00 millions Quarterly AMGN's Income Statement
New: More AMGN's historic Operating Income Growth >>


AMGN Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - -16.41 % -5.53 % -5.74 %




Operating Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Amgen Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
348.14 % 4.74 % -100 %
(Sep. 30, 2006)   (Mar 31 2022)


AMGN's I. Quarter Q/Q Operating Income Comment
Current accomplishment of 0.00 millions by Amgen Inc look even more unfavourable if you take a look at Operating Loss 7,639.00 millions in the previous quarter.

Within Biotechnology & Pharmaceuticals industry 18 other companies have achieved higher Operating Income quarter on quarter growth. While Amgen Inc 's Operating Income growth quarter on quarter, overall rank is 1799.


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #19
Healthcare Sector #135
Overall #1799
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #19
Healthcare Sector #135
Overall #1799
Operating Income Q/Q Growth Statistics
High Average Low
348.14 % 4.74 % -100 %
(Sep. 30, 2006)   (Mar 31 2022)


AMGN's I. Quarter Q/Q Operating Income Comment
Current results of 0.00 millions by Amgen Inc come out even worse if you take a look at 7,639.00 millions in the forth quarter.

Within Biotechnology & Pharmaceuticals industry 18 other companies have achieved higher Operating Income quarter on quarter growth. While Amgen Inc 's Operating Income growth quarter on quarter, overall rank is 1799.


Amgen Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Operating Income 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
In the Mar 31 2022 period, Amgen Inc 's cumulative trailing twelve month Operating Income remained unchanged compare to the same period a year ago.

Amgen Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
In the Mar 31 2022 period, Amgen Inc 's cumulative trailing twelve month Operating Income remained unchanged compare to the same period a year ago.

Amgen Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Pharmaceuticals Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
AMGN's Operating Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for AMGN's Competitors
Operating Income Growth for Amgen Inc 's Suppliers
Operating Income Growth for AMGN's Customers

You may also want to know
AMGN's Annual Growth Rates AMGN's Profitability Ratios AMGN's Asset Turnover Ratio AMGN's Dividend Growth
AMGN's Roe AMGN's Valuation Ratios AMGN's Financial Strength Ratios AMGN's Dividend Payout Ratio
AMGN's Roa AMGN's Inventory Turnover Ratio AMGN's Growth Rates AMGN's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2022
Lemaitre Vascular Inc-0.21%$ -0.214 millions
Intuitive Surgical Inc -2.09%$ -2.087 millions
Innoviva Inc -2.21%$ -2.207 millions
Stryker Corp-2.61%$ -2.614 millions
National Research Corporation-2.69%$ -2.687 millions
Diffusion Pharmaceuticals Inc -2.77%$ -2.773 millions
Msa Safety Inc-3.11%$ -3.111 millions
Nuvasive Inc-3.28%$ -3.282 millions
Royalty Pharma Plc-4.18%$ -4.178 millions
Phibro Animal Health Corp-4.66%$ -4.659 millions
Co diagnostics Inc -4.94%$ -4.942 millions
National Healthcare Corp-6.60%$ -6.602 millions
Natus Medical Inc-7.50%$ -7.500 millions
Dexcom Inc -10.02%$ -10.022 millions
Biomx Inc -10.20%$ -10.196 millions
Pacira Biosciences inc -10.52%$ -10.516 millions
Align Technology inc -12.14%$ -12.138 millions
Lifevantage Corp-12.60%$ -12.596 millions
Tivity Health Inc -12.86%$ -12.858 millions
Rackspace Technology Inc -13.64%$ -13.636 millions
Diversified Healthcare Trust-15.19%$ -15.194 millions
Community Health Systems Inc -17.18%$ -17.178 millions
Fonar Corporation-18.88%$ -18.878 millions
Universal Health Services Inc -21.24%$ -21.244 millions
Molecular Templates Inc -21.64%$ -21.642 millions
Quest Diagnostics Inc-22.27%$ -22.273 millions
Davita Inc -23.56%$ -23.564 millions
Fulgent Genetics Inc -24.35%$ -24.348 millions
Zimmer Biomet Holdings Inc -25.30%$ -25.301 millions
Reynolds Consumer Products Inc -25.44%$ -25.439 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

IGTA's Profile

Stock Price

IGTA's Financials

Business Description

Fundamentals

Charts & Quotes

IGTA's News

Suppliers

IGTA's Competitors

Customers & Markets

Economic Indicators

IGTA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071